Free Trial

Tejas Savant Analyst Performance

Executive Director / Senior Healthcare Equity Analyst at Morgan Stanley

Tejas Savant is a stock analyst at Morgan Stanley focused in the medical sector, covering 17 publicly traded companies. Over the past year, Tejas Savant has issued 29 stock ratings, including buy, hold, and sell recommendations. While full access to Tejas Savant's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tejas Savant's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
32 Last 4 Years
Buy Recommendations
37.50% 12 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy37.5%12 ratings
Hold59.4%19 ratings
Sell3.1%1 ratings

Out of 32 total stock ratings issued by Tejas Savant at Morgan Stanley, the majority (59.4%) have been Hold recommendations, followed by 37.5% Buy and 3.1% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
82.4% of companies on NASDAQ
14 companies
NYSE
17.6% of companies on NYSE
3 companies

Tejas Savant, an analyst at Morgan Stanley, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
16 companies
94.1%
Transportation
1 company
5.9%

Tejas Savant of Morgan Stanley specializes in stock coverage within the Medical sector, with additional focus on Transportation companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
5 companies
29.4%
MED INSTRUMENTS
4 companies
23.5%
MEDICAL INFO SYS
2 companies
11.8%
MEDICAL SERVICES
2 companies
11.8%
TRANS - SERVICES
1 company
5.9%
MED PRODUCTS
1 company
5.9%
MED - GENERIC DRG
1 company
5.9%
ANALYTICAL INSTRUMENTS
1 company
5.9%

Tejas Savant's Ratings History at Morgan Stanley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
10x Genomics stock logo
TXG
10x Genomics
8/12/2025Lower Price Target$12.31$17.00Overweight
Tempus AI, Inc. stock logo
TEM
Tempus AI
8/12/2025Boost Price Target$60.82$68.00Overweight
Veracyte, Inc. stock logo
VCYT
Veracyte
8/8/2025Set Price Target$27.37$28.00Underweight
Illumina, Inc. stock logo
ILMN
Illumina
8/4/2025Boost Price Target$96.82$105.00Equal Weight
Avantor, Inc. stock logo
AVTR
Avantor
8/4/2025Lower Price Target$11.40$12.00Equal Weight
Hologic, Inc. stock logo
HOLX
Hologic
7/31/2025Boost Price Target$66.85$69.00Equal Weight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
7/30/2025Set Price Target$5.22$8.00Equal Weight
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
5/28/2025Lower Price Target$2.49$7.00Equal Weight
10x Genomics stock logo
TXG
10x Genomics
5/19/2025Lower Price Target$9.01$18.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
5/12/2025Lower Price Target$80.00$100.00Equal Weight
Tempus AI, Inc. stock logo
TEM
Tempus AI
5/9/2025Boost Price Target$62.51$65.00Overweight
CryoPort, Inc. stock logo
CYRX
CryoPort
5/5/2025Lower Price Target$5.74$7.00Equal Weight
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
5/5/2025Boost Price Target$9.72$9.00Equal Weight
Hologic, Inc. stock logo
HOLX
Hologic
5/5/2025Lower Price Target$53.82$65.00Equal Weight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
5/1/2025Lower Price Target$7.02$10.00Equal Weight
Avantor, Inc. stock logo
AVTR
Avantor
4/28/2025Set Price Target$12.93$15.00Equal Weight
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
3/25/2025Lower Price Target$2.35$5.00Equal Weight
GRAIL, Inc. stock logo
GRAL
GRAIL
3/18/2025Boost Price Target$27.06$20.00Equal Weight
Tempus AI, Inc. stock logo
TEM
Tempus AI
3/6/2025Boost Price Target$53.06$60.00Overweight
Natera, Inc. stock logo
NTRA
Natera
3/5/2025Boost Price Target$142.35$185.00Overweight
10x Genomics stock logo
TXG
10x Genomics
2/14/2025Lower Price Target$11.94$26.00Overweight
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2/11/2025Boost Price Target$201.54$250.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
2/11/2025Lower Price Target$102.44$136.00Equal Weight
Avantor, Inc. stock logo
AVTR
Avantor
2/10/2025Lower Price Target$18.82$25.00Overweight
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
1/31/2025Boost Price Target$602.56$678.00Overweight
10x Genomics stock logo
TXG
10x Genomics
1/13/2025Lower Price Target$16.43$28.00Overweight
Hologic, Inc. stock logo
HOLX
Hologic
1/13/2025Lower Price Target$70.44$82.00Equal Weight
Illumina, Inc. stock logo
ILMN
Illumina
1/13/2025Lower Price Target$143.81$150.00Equal Weight
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
1/13/2025Lower Price Target$556.53$647.00Overweight